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Abstract Laparoscopic adjustable gastric banding (LAGB)
andvertical-bandedgastroplasty(VBG) aresurgicaltreatment
modalities for morbid obesity. This prospective study
describes the long-term results of LAGB and VBG. One
hundred patients were included in the study. Fifty patients
underwent LAGB and 50 patients, open VBG. Study
parameters were weight loss, changes in obesity-related
comorbidities, long-term complications, re-operations includ-
ing conversions to other bariatric procedures and laboratory
parameters including vitamin status. From 91 patients (91%),
data were obtained with a mean follow-up duration of
84 months (7 years). Weight loss [percent excess weight loss
(EWL)] was significantly more after VBG compared with
LAGB, 66% versus 54%, respectively. All comorbidities
significantly decreased in both groups. Long-term complica-
tions after VBG were mainly staple line disruption (54%) and
incisional hernia (27%). After LAGB, the most frequent
complications were pouch dilatation (21%) and anterior
slippage (17%). Major re-operations after VBG were per-
formed in 60% of patients. All re-operations following were
conversions to Roux-en-Y gastric bypass (RYGB). In the
LAGB group, 33% of patients had a refixation or replacement
of the band, and 11% underwent conversion to another
bariatric procedure. There were no significant differences in
weight loss between patients with or without re-interventions.
No vitamin deficiencies were present after 7 years, although
supplement usage was inconsistent. This long-term follow-up
study confirms the high occurrence of late complications after
restrictive bariatric surgery. The failure rateof65% after VBG
is too high, and this procedure is not performed anymore in
ourinstitution.There-operationrateafterLAGBisdecreasing
as a result of new techniques and materials. Results of the re-
operations are good with sustained weight loss and reduction
in comorbidities. However, in order to achieve these results, a
durable and complete follow-up after restrictive procedures is
imperative.
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Introduction
Morbid obesity, defined as a body mass index (BMI) of
>40 kg/m² or >35 kg/m² with obesity-related comorbidities, is
a rapidly growing problem in the western society. In the USA,
about 6 million people currently have a BMI of >40 kg/m²,
and another 10 million people have a BMI of >35 kg/m² with
comorbidities. Worldwide, the incidence of morbid obesity
has doubled, and about 300 million people are now obese [1,
2]. In The Netherlands, the prevalence is less disturbing, but
the incidence of morbid obesity is rising progressively to
1.5% of the total population [3]. At this moment, surgical
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results in sufficient long-term weight loss. Non-surgical
approaches, like low-energy diets and behavior modification,
are not successful in the long-term with respect to maintaining
weight loss and decreasing obesity-related comorbidities [4, 5].
Gastric restrictive surgery was introduced in the mid-
1970s with transverse gastroplasty and has been developed
and improved since. This procedure evolved to vertical-
banded gastroplasty (VBG) as described by Mason and
others and has been performed on many patients worldwide
[6, 7]. In 1993, a new type of gastric restrictive surgery was
introduced in the form of laparoscopic adjustable gastric
banding (LAGB) with the advantages of a minimal invasive
technique and adjustability and as a result more gradual
weight loss [8]. In 1998, no randomized trials were
published that compared these two operative techniques.
A randomized controlled clinical trial was conducted in our
institution by van Dielen et al. The 2-year results of this
study demonstrated a significantly shorter hospital stay
after LAGB (3.5 versus 6.8 days), a significantly greater
weight loss after VBG (% excess weight loss (EWL) of
72.7% versus 53.3%), significant decrease of all comorbid-
ities in both groups and a higher percentage of major re-
operations after VBG (36% versus 28%) and incisional
hernias (16% versus 0%) [9]. Prospective trials comparing
operative techniques are few in bariatric surgery, and only
short- or mid-term results are reported [10–12]. Few studies
have published long-term results [13, 14]. All patients
participating in the aforementioned study have had initial
surgery more than 5 years ago. The present study describes
the long-term results of this prospectively followed group
of patients after restrictive bariatric procedures.
Patients and Methods
Patients
Patients were considered eligible for the study if their BMI
was >40 or >35 kg/m
2 with obesity-related comorbidities.
One hundred patients were included. In the initial study,
patients were randomly assigned to LAGB (50) or open
VBG (50) using a computer-generated randomization list.
The initial study and long-term follow-up study were
approved by the medical ethical committee of the Maas-
tricht University Medical Centre, The Netherlands.
Methods
During the initial study, demographic data, BMI, medica-
tion, medical history, and comorbidities were recorded as
well as intra- and postoperative complications and length of
hospital stay. After discharge, all patients were evaluated in
the outpatient clinic after 1 and 6 weeks and after 3, 6, and
12 months. After this period, patients were evaluated once a
year. The following data was obtained: body weight, blood
pressure, pulse, comorbidities, medication, symptoms and
complaints, present dietary habits, complications, re-
operations, conversions, and laboratory measurements
(hemoglobin, urea, creatinin, aspartate aminotransferase
(ASAT), alanine aminotransferase (ALAT), albumin, total
protein, cholesterol, triglycerides, high density lipoprotein
(HDL) and low density lipoprotein (LDL)). Furthermore, in
order to investigate vitamin status and possible deficiencies
after restrictive surgery, patients were asked about the use
of vitamin supplements and a set of parameters (iron, zinc,
vitamin B1, B6, B12, and folic acid) was measured during
the last follow-up visit.
Surgical Technique
All patients received general anesthesia, a single dose of
preoperative antibiotics, and a double daily dose of low-
molecular-weight heparin. The surgical techniques of LAGB
and open VBG are described in detail elsewhere [9]a sw e l la s
the technique of converting VBG to RYGB [15]. In summary,
in case of VBG, a small pouch of the stomach was created
with a 4-row linear stapler (TA-90B, United States Surgical
Corp., Norwalk, CT), and a Dacron band of 5.0 cm in
circumference was placed through the window formed by a
circular stapler (Premium Plus CEEA 31 mm, United States
Surgical Corp., Norwalk, CT). Laparoscopic gastric banding
was, in all cases, performed by placing a 9.75-cm lap-band
(Allergan, Santa Barbara, CA). During the study period, the
LAGB was insufflated when weight loss was insufficient (less
than approximately 1 kg per week) with the first insufflation at
least 6 weeks postoperatively. After the first 32 patients, the
surgical technique of placing the laparoscopic band was
changed from “perigastric” to “pars flaccida” because of
several international reports suggesting the latter to be a
superior technique with fewer complications [16–18].
Statistical Analysis
Statistical analyses were performed using the SPSS 15.0.0
statistical package (SPSS Inc., Chicago, IL, USA). The
Student's t test was used to calculate differences between
the groups. In case of a skewed distribution, the Mann–
Whitney U test was used for comparison between the
groups and the Wilcoxon signed-rank test for comparison in
one group throughout time. Analysis of the differences in
postoperative complications and re-operations between the
perigastric and pars flaccida technique in the LAGB group
was performed with the Chi-square test. Data are given as
mean and standard deviation. A p value of p<0.05 was
denoted as statistically significant.
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Preoperative Data
Preoperative patient characteristics are summarized in
Table 1. Both groups consisted of 50 patients with a male
to female ratio of 1 to 4. Mean age, weight, BMI, and total
number of obesity-related comorbidities did not differ
significantly between the groups.
Patients
Follow-up for the total group was 91% with a mean period
in both groups of 84 months (7 years), ranging from a
minimum of 67 months (5.6 years) to a maximum of
101 months (8.4 years). In the direct postoperative period,
two patients died in the VBG group, one patient due to
sepsis as a result of leakage, and one patient due to
respiratory complications of a pre-existing pneumonia. Five
patients were lost to follow-up. As a result, 43 patients were
included in the final analysis in the VBG group. In the
LAGB group, two patients died during follow-up as a result
of gynecological malignancies. Data from these two
deceased patients are included in the analysis until the
moment of death. Two patients were lost to follow-up. As a
result, 48 patients from the LAGB group were analyzed.
Long-Term Complications
Complications were classified as “major” or “minor”
depending on the need for a surgical re-intervention. All
complications that required a re-operation or conversion to
another bariatric procedure were classified as “major”. All
complications that were managed with conservative meas-
ures, medication, or were treated under local anesthesia
were considered “minor”. Major and minor complications
are summarized in Table 2.
In both groups, many long-term complications occurred
requiring either a re-operation or conversion to another
bariatric procedure. A flow chart describing the follow-up
data including re-operations and conversions is provided in
Fig. 1.
Major Complications
Mean time between the first operation and the re-operation
or conversion was 2 years. However, this ranged from a
minimum of 6 months to a maximum of 7 years.
Procedure-specific major complications occurred in 60%
of patients after VBG (26/43 patients) and included staple
line dehiscence (n=22) and recurrent outlet stenosis (n=4).
In all cases, an open conversion to RYGB was performed.
Ten patients (23%), including four patients who already
underwent conversion to RYGB, developed a symptomatic
incisional hernia and underwent open repair with mesh.
Two patients had complications after the conversion to
RYGB necessitating another re-operation (8%). This in-
cluded one patient with serious weight regain 2 years after
conversion. A distal gastric bypass was performed. Another
patient developed a recurrent stenosis of the anastomosis,
and a new gastrojejunostomy was created.
Complications necessitating a re-operation after LAGB
were also frequent. In total, 44% (21/48 patients) under-
went either re-operation or conversion to another bariatric
procedure during follow-up. Main causes were pouch
dilatation (n=10), anterior slippage (n=8), band erosion
(n=2), and band leakage (n=1). The re-operation rate in
perigastric (n=32) and pars flaccida (n=18) operated
patients was 41% and 33%, respectively. Performed
laparoscopic re-operations were band refixation (14
patients) and band replacement (two patients). In five
patients, refixation or replacement of the band was not
possible because of band erosion (two patients) and severe
pouch dilatation (three patients). These patients were
converted to open biliopancreatic diversion (BPD) in case
Table 1 Preoperative patient characteristics
LAGB VBG P value
a
Patients (n)5 0 5 0 –
M/F (n) 10:40 10:40 –
Age (years) 39±8 37±9 0.32
Weight (kg) 133±21 131±24 0.87
BMI (kg/m²) 47±6 47±6 0.97
Total comorbidities (n) 1.3±1.0 1.3±1.1 0.97
at test
Table 2 Long-term complications
LAGB VBG “non-
converted”
RYGB “converted
VBG”
(n=48) (n=17) (n=26)
Reflux 3 (6%) 1 (6%) 0 (0%)
Vomiting 20 (42%) 7 (41%) 0 (0%)
Dysphagia 1 (2%) 1 (6%) 1 (4%)
Port-related
problems
5 (10%) ––
Re-operations 16 (33%) 11 (26%) 2 (8%)
Conversions 5 (10%) 26 (65%) –
Second re-
operation
1 (5%) 2 (8%) –
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dilatation.
After re-operation, one patient (1/21; 5%) developed a
complication which necessitated a second re-operation.
This patient had a re-slippage and underwent another
laparoscopic refixation.
Minor Complications
After VBG, minor problems which were still present after
7 years were vomiting (more than once a week; 41%),
reflux (6%), and dysphagia (6%). All patients with
vomiting more than once a week were patients still having
the VBG configuration after 7 years while no patients
converted to RYGB complained of vomiting. Reflux and
dysphagia occurred in the converted patients in 0% and 4%,
respectively. After LAGB, patients reported the same minor
problems: vomiting (42%), reflux (6%), and dysphagia
(2%) without significant differences between uncomplicat-
ed and re-operated LAGB patients. Furthermore, 10% of
patients had port-related problems (dislocation in all cases)
and were successfully treated under local anesthesia. No
port infections occurred.
Weight Loss
LAGB versus VBG
Percent excess weight loss (% EWL) 2 and 7 years after
surgery are represented in Table 3. In both groups, weight
significantly decreased in the first two postoperative years.
Weight loss was significantly better after VBG compared with
LAGB (EWL of 73% versus 55%, respectively). In the non-
converted VBG group, a slight but not significant weight gain
occurredafter7years(73%after2yearsand69%after7years).
In the LAGB group, after excluding the five patients that
underwent conversion to another bariatric procedure, weight
loss remained successful and unchanged after 7 years (55%
after 2 years and 54% after 7 years). Furthermore, there was no
difference in weight loss between patients with or without re-
operation (both EWL of 54%). However, weight loss remained
significantly greater after VBG compared with LAGB.
Fig. 1 Flow chart of
follow-up, re-operations,
and conversions
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When interpreting long-term weight loss results, it is
important to realize that 60% of VBG patients were converted
to RYGB. Preoperative BMI of patients eventually converted
to RYGB was significantly higher compared with non-
converted VBG patients (BMI of 48 versus 43, respectively).
Two years after the initial operation, 11 patients were already
converted to RYGB. At this point, EWL was not significantly
different between converted and non-converted patients (66%
and 73%, respectively) while after 7 years weight loss was the
same in non-converted VBG patients and converted RYGB
patients (both EWL of 69%).
Comorbidities
In both groups, the most prevalent obesity-related comorbid-
ities were type 2 diabetes mellitus (T2DM), hypertension, and
jointproblems(5,7,and28patientsintheLAGBgroupand7,
10, and 29 patients in the VBG group). All obesity-related
comorbidities significantly decreased in both groups 2 years
after surgery (Table 4). However, an increase in certain
comorbidities was observed after 7 years. For example, five
patients had T2DM compared with one patient after 2 years.
In the VBG group, six patients had hypertension, although
only one patient had this after 2 years. Joint problems were
again reportedby17 patients inbothgroupscomparedwith 11
and 12 patients after 2 years in the LAGB and VBG group,
respectively. However, the joints involved changed from
mainly ankle and knee problems before operation to back
problems afterwards. However, in the long-term, the total
number of comorbidities per patient decreased after both
procedures from 1.3 to 0.6 (p=0.01). Apart from the increase
in T2DM in the LAGB group, there were no significant
differences between the two groups. Also, as presented in
Table 5, there were no significant differences in the decrease
of comorbidities between VBG patients with or without
conversion to RYGB (p=0.8).
Laboratory Parameters and Vitamin Status
Laboratory parameters (hemoglobin, urea, creatinin, ASAT,
ALAT, albumin, total protein, cholesterol, triglycerides, HDL,
andLDL) and vitamin status(iron,zinc, vitamin B1,B6, B12,
andfolic acid) 7 years after restrictive surgeryare summarized
in Table 6. There were no significant differences between
patients with LAGB compared with VBG. Furthermore, all
values in both groups were within the normal range except
high-density lipoprotein which was 2.0 mmol/L (normal
range, 0.7–1.5 mmol/L) in the VBG group. Comparing
patients with or without conversion to RYGB in the VBG
group did not change these results. In Table 7, the laboratory
parameters of converted and non-converted VBG patients are
listed. No significant differences were found, and no
parameters were out of the normal range except HDL (2.2,
normal range 0.7–1.5 mmol/L) in the converted group.
Noteworthy is that all vitamins were within the normal
range in all groups (LAGB, VBG, and RYGB), and no
deficiencies were present after 7 years. However, there was a
difference in medication use in the form of vitamin supple-
Table 3 Weight loss after 2 and 7 years
LAGB (n=48) VBG “non-converted” (n=17) RYGB “converted VBG” (n=26)
BMI (preoperative) 47±6 (n=50) 43±7 (n=17) 48±6 (n=26)
BMI (2 years) 34±6 (n=50) 30±5 (n=36) 33±7 (n=11)
EWL (2 years) 55%±22 (n=49) 73%±23 (n=36) 66%±27 (n=11)
BMI (7 years) 35±7 (n=43)
a 31±6 (n=17) 31±5 (n=26)
EWL (7 years) 54%±25 (n=43)
a 69%±22 (n=17) 69%±24 (n=26)
aConverted LAGB patients (n=5) were excluded
Table 4 Obesity-related comorbidities 2 and 7 years postoperatively (LAGB and VBG patients)
LAGB VBG
Preop (n=50) 2 years (n=50) 7 years (n=48) Preop (n=50) 2 years (n=48) 7 years (n=43)
Diabetes 5 1 5 7 1 0
Hypertension 7 3 4 10 1 6
Joint problems 28 11 17 29 12 17
Hyperchol. 2 1 0 2 1 1
OSAS 1 0 0 1 0 0
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were significantly more used by LAGB patients compared
with VBG and RYGB patients (55% versus 32%, respective-
ly). A pattern in vitamin supplement usage and vitamin levels
was not apparent. Patients without any supplements also had
normal vitamin levels. Vitamin B12 injections (every
3 months) and iron supplements were used more frequently
afterVBGandRYGBthanafter LAGB (29%versus21%and
13% versus 6% of patients, respectively).
Discussion
Morbid obesity and its related comorbidities is a worldwide
epidemic. Surgery is, in contrast to conventional treatment
modalities, the only treatment with a proven long-lasting
effect on weight and comorbidities and has a positive effect
on the quality of life [19, 20]. Weight loss more than
5 years after VBG varies in the literature from 30% to 59%
EWL [13, 14, 21] while, after LAGB, it varies from 56% to
62% EWL ([13, 14, 22]. The long-term results of O'Brien et
al. show that, 10 years after gastric banding, it is still
successful, and weight loss is comparable with gastric
bypass (59% and 52% EWL, respectively) [23]. Most
studies show a rapid weight loss after VBG with a weight
regain after 2 years while patients with LAGB tend to lose
weight more slowly but for a prolonged period. Our study
results are consistent with the literature with 73% and 55%
EWL after 2 years and 69% and 54% EWL after 7 years for
VBG and LAGB, respectively. Weight loss was not
Table 5 Obesity-related comorbidities 2 and 7 years postoperatively (VBG and converted VBG to RYGB patients)
VBG “non-converted” (n=17) RYGB “converted VBG” (n=26)
Preop (n=50) 2 years (n=36) 7 years (n=17) 2 years (n=11) 7 years (n=26)
Diabetes 7 1 0 0 0
Hypertension 10 1 3 0 3
Joint problems 29 6 8 6 9
Hyperchol. 2 0 0 1 1
OSAS 1 0 0 0 0
Table 6 Laboratory measurements: LAGB versus VBG/GB
LAGB (n=48) VBG (n=43) Normal range P value
a
Hemoglobin 8.1 7.9 7.5–10.0 (mmol/L) 0.61
ASAT
b 17 20 <35 (U/L) 0.13
ALAT
c 21 23 <40 (U/L) 0.58
Albumin 39 39 35–50 (g/L) 0.94
Total protein 69 67 60–80 (g/L) 0.49
Cholesterol 5.2 5.0 4.3–5.6 (mmol/L) 0.47
Triglycerides 1.1 1.1 0.80–2.00 (mmol/L) 0.94
HDL
d 1.3 2.0 0.7–1.5 (mmol/L) 0.22
LDL
e 3.5 3.0 1.9–4.5 (mmol/L) 0.05
Iron 12.5 12.8 11.0–30.0 (μmol/L) 0.86
Zinc 12.7 12.4 10–18 (μmol/L) 0.70
Vitamin B1 126 135 74–222 (nmol/L) 0.27
Vitamin B6 61 78 20–122 (nmol/L) 0.16
Vitamin B12 0.23 0.27 0.15–0.67 (nmol/L) 0.18
Folic acid 13.9 17.5 7.0–45.4 (mmol/L) 0.24
at test
bAspartate aminotransferase
cAlanine aminotransferase
dHigh-density lipoprotein
eLow-density lipoprotein
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groups. Although weight loss was significantly more after
VBG compared with LAGB, it is important to notice that
60% of patients in the VBG group no longer had the VBG
configuration but were converted to RYGB because of
complications. On the other hand, weight loss was the same
after 7 years for patients in the VBG group with or without
conversion to RYGB (both EWL of 69%). In terms of
weight loss, successful bariatric surgery is defined as the
maintenance of EWL of at least 50%. In our patient group,
this applies to 79% of VBG patients (converted and non-
converted) and 60% of LAGB patients.
Thedecreaseinobesity-relatedcomorbiditiesafterbariatric
surgery is well-documented and depends on the weight loss
and the type of surgery [20, 24–26]. Our study confirms this
once again, but interestingly, an increase in T2DM was
observed 7 years after LAGB while it was almost non-
existent after 2 years. A clear explanation for this increase
from one to five patients was not found. Weight loss in these
five patients was EWL 44% and for the total group of LAGB
patients 54% (ns). They also did not experience a rapid
weight gain during the final period of follow-up. Further-
more, three patients in this diabetic group did not have any
complications while two patients had a band slippage and
underwent refixation. There is no literature available de-
scribing a possible increase in diabetes many years after
LAGB. Possibly, a combination of factors could be
responsible for this phenomenon. The 10% difference in
weight loss could be important because a resolution of
T2DM is possible after only 10% weight loss [27, 28].
Furthermore, the aging of the study population during
follow-up could be a factor in the development of T2DM.
Awide range of laboratory measurements was investigated
7 years after surgery including hemoglobin, urea, creatinin,
ASAT, ALAT, albumin, total protein, cholesterol, triglycer-
ides, HDL, and LDL. There were no significant differences
between the groups and except high-density lipoprotein in the
VBG and converted RYGB patients, all values were within
normal ranges. The values of minerals and vitamins (iron,
zinc, vitamin B1, B6, B12, and folic acid) are especially of
interest.Inallgroups,includingtheconvertedRYGBpatients,
all levels were within the normal range implying no
deficiencies were present. In the literature, comparison
betweenrestrictive andmoremalabsorptiveproceduresshows
thatdeficienciesaremuchlesscommonafterpurelyrestrictive
procedures because the gastrointestinal tract remains intact
and absorption is normal [29, 30]. This is confirmed in
several reports except that low levels of folic acid are
frequently observed caused by a difference in eating habits
after surgery (less wholemeal bread, vegetables, and fruit)
[31, 32]. This is considered the most important reason to
recommend vitamin supplementation after restrictive surgery.
However, in the present study, the postoperative levels of
folic acid were normal irrespective of vitamin supplement
Table 7 Laboratory measurements after 7 years: VBG versus GB
VBG “non-converted” (n=17) RYGB “converted VBG” (n=26) Normal range P value
a
Hemoglobin 7.7 7.9 7.5–10.0 (mmol/L) 0.79
ASAT
b 18 21 <35 (U/L) 0.32
ALAT
c 20 25 <40 (U/L) 0.32
Albumin 41 38 35–50 (g/L) 0.13
Total protein 68 66 60–80 (g/L) 0.58
Cholesterol 4.8 4.9 4.3–5.6 (mmol/L) 0.92
Triglycerides 0.9 1.2 0.80–2.00 (mmol/L) 0.31
HDL
d 1.4 2.2 0.7–1.5 (mmol/L) 0.32
LDL
e 2.9 3.0 1.9–4.5 (mmol/L) 0.95
Iron 15.0 11.6 11.0–30.0 (μmol/L) 0.21
Zinc 12.9 12.2 10–18 (μmol/L) 0.53
Vitamin B1 135 136 74–222 (nmol/L) 0.93
Vitamin B6 91 69 20–122 (nmol/L) 0.39
Vitamin B12 0.27 0.26 0.15–0.67 (nmol/L) 0.85
Folic acid 17.5 16.1 7.0–45.4 (mmol/L) 0.53
at test
bAspartate aminotransferase
cAlanine aminotransferase
dHigh-density lipoprotein
eLow-density lipoprotein
OBES SURG (2010) 20:1617–1626 1623usage. The supplement use was low in both groups but
significantly higher in the LAGB group (55%) compared
with the VBG/RYGB group (32%). Continued vitamin use is
probably associated with regular follow-up, and this tends to
be higher after LAGB because of visits before and after
insufflations. On the other hand, vitamin B12 injections
(every 3 months) and iron supplements were used more
frequently after VBG and RYGB than after LAGB (29%
versus 21% and 13% versus 6% of patients, respectively).
The latter can be explained by the 60% conversion rate to
RYGB in the VBG group. The deficiency of vitamin B12
and iron is well-known after RYGB because of the bypassed
stomach and proximal intestine [33–35], and therefore,
vitamin monitoring and supplementation is mandatory after
RYGB. In our study group, a pattern in vitamin supplement
usage and vitamin levels was not apparent. Patients without
any supplements also had normal vitamin levels, and this
issue has been discussed in the literature [36]. It is mostly
explained by medication adherence which is, in case of
bariatric surgery, below 50% and deteriorates during follow-
up [30, 37]. No randomized trials on this subject are
published to provide a definitive answer if supplements are
needed after purely restrictive procedures, and therefore, it is
still common practice to prescribe vitamin supplements to all
bariatric patients. Although our results are not consistent,
based on the available literature and possible consequences
of deficiencies, continuation of this policy seems justified.
RevisionalsurgeryisoftennecessaryafterVBGbecauseof
stoma stenosis, pouch enlargement, or stapler line dehiscence.
Percentages in the literature range from 10% to 50% and are
strongly associated with the completeness and duration of
follow-up [38–42]. Also, developments in VBG techniques
may possibly lead to better results with a lower re-operation
rate, e.g., the Mason McLean operation with partition of the
stomach instead of only stapling. However, no long-term
results of this procedure are described in the literature, so a
comparison with standard VBG or LAGB is not possible. In
the present study, the mean time between the primary
operation and the re-operation was 2 years with a range
from 6 months to 7 years. Therefore, in order to present
reliable re-operation rates after VBG, a minimum follow-up
period of 3 years is necessary. Balsiger et al. described a re-
operation rate of 19% 10 years after VBG [21]. Comparable
results were found by van de Weijgert et al. with a re-
operation rate of 18% after a mean period of 7.2 years [43].
Studies by van Gemert et al. and MacLean et al. reported
higher rates (31% and 36%, respectively) after 52 months
and 2 to 5 years of follow-up [39, 41]. Finally, the
prospective study by Miller et al. (follow-up of 92 months)
is most comparative with our results with a re-operation rate
after VBG of 49.7% [14]. Purely technical failure after
V B Go c c u r r e di n6 5 %o fo u rp a t i e n t s ,a n di na l lc a s e s ,
conversion to RYGB was performed. Conversion from
VBG to RYGB has been described in literature with
positive results. Sugerman et al. reported on 53 patients
where EWL increased from 36% to 67% after the conversion
[44]. The patient group of Cordera et al. showed a decrease
in BMI of 46 to 35 kg/m² after conversion [45]. Kfoury et al.
performed a distal RYGB in 45 patients after failed VBG.
Results after a follow-up period of at least 2 years were
available for 29 patients, and % EWL was 74% in this group
[46]. Finally, the conversion led to a decrease in BMI from
40 to 32 kg/m² at 16 months postoperatively in the group
described by Gonzalez et al. [47]. We also reported on 101
patients who were converted from failed VBG to RYGB and
demonstrated good results on weight loss, comorbidities, and
patients' symptoms [15]. The present study confirms the
positive results of this conversion with a long-term EWL of
69% and a low re-intervention rate (8%).
The rate of re-operations after LAGB differs tremendously
in literature from 2% to 80% [48]. Several reasons for these
differences have been proposed. Firstly, results vary accord-
ing to the used surgical technique, either perigastric or pars
flaccida, the latter having better results especially due to a
decrease in band slippages [18, 49]. In two randomized
studies from Weiner et al. and O'Brien et al., the pars flaccida
technique was demonstrated to be a safer technique with less
complication and is therefore nowadays considered best
surgical practice [18, 49]. In a previously reported study
from our institution based on a study population operated
more recently than the population from the present study, the
re-operation rate decreased significantly from 42% to 8%
after introduction of the pars flaccida technique. This was
mainly due to a decrease in band slippage and pouch
dilatation from 29% in the perigastric group to 4% in the
pars flaccida group [48]. In the present study, this difference
is not confirmed; the re-operation rate after perigastric and
pars flaccida operated patients was 41% and 33%, respec-
tively (ns). However, in this consecutive group of patients,
the perigastric technique was used in 30 patients and the pars
flaccida technique in 18 patients, the latter representing our
first experience with this technique (reviewer no. 1, comment
no. 1). Therefore, our experience with the different techni-
ques is not comparable in this group. This might explain the
non-significant difference in re-operation rate.
The second important issue explaining differences in re-
operation rate after LAGB is follow-up time. In the present
study, mean time between the primary operation and the re-
operation because of complications after LAGB was 3 years.
Most publications report on short-term results after LAGB
which explains re-operation rates as low as 2%. However, a
follow-upofa reasonablepatient populationbeyond3yearsis
necessary for a reliable estimation of the re-operation rate. For
example, the re-operation rate in a retrospective study by
Christou et al. was 16.1% after 3 years, but only one third of
patients were available for follow-up [50]. In a case-
1624 OBES SURG (2010) 20:1617–1626controlled study by Cottam et al., the re-operation rate was
53% in the first year, decreasing to 0% in the third year.
However, follow-up after 3 years was only 25% [51]. The
prospective long-term study by Miller et al., with a follow-up
rate of 92%, is therefore the only comparable study with a
mean follow-up of 92 months and a minimum of 60 months.
They reported a re-operation rate of 8% which is low
compared with the 44% from the present study [14].
Whether the perigastric or pars flaccida technique was used
is unclear. As mentioned above, since the introduction of the
pars flaccida technique, our re-operation rate decreased to
from 44% (follow-up 84 months) to 8% (follow-up of
48 months) [48].
As we previously reported, re-operations after LAGB,
especially refixation of the band or replacement, are highly
successful [48]. Weiss et al. reported on 73 patients who
underwent a surgical revision after LAGB. After a follow-up
period of 42 months, BMI decreased from 37.8 to 29.5 kg/m²
[52]. Peterli et al. performed 250 operations and re-operated
on 39 patients (16%) because of failed LAGB. After re-
operation, 5.3% of patients developed a second failure of the
band, but re-slippages were not observed [53]. These
positive results of re-operations after LAGB are confirmed
in the present study as only one patient had a re-slippage
after refixation of the band (5%). Weight loss was successful
after re-operation and more importantly, the same in patients
with or without re-operation (both EWL of 54%).
In conclusion, VBG results in long-term weight loss and
improvement of obesity-related comorbidities. However,
because of the 65% failure rate and the necessity to perform
a conversion in case of failure, we do not offer VBG to our
patients nowadays. Although the re-operation rate after
long-term follow-up is also high in LAGB patients, the
results of these re-operations (in most cases only refixation
of the band) are good. Many improvements have been
made, e.g., the perigastric instead of the pars flaccida
technique and low pressure–high volume bands instead of
high pressure–low volume bands with a dramatic decrease
in re-operation rate as a result. LAGB is the least
complicated procedure in comparison with more invasive
and non-reversible procedures like RYGB and BPD.
Therefore, we still recommend and perform LAGB, but
patients need to be informed extensively before the
operation and follow-up needs to be durable and complete.
Conclusion
This long-term follow-up study confirms the high occur-
rence of late complications after restrictive bariatric surgery.
The failure rate of 65% after VBG is too high, and this
procedure is not performed anymore in our institution. The
re-operation rate after LAGB is decreasing as a result of
new techniques and materials. Results of the re-operations
are good with sustained weight loss and reduction in
comorbidities. However, in order to achieve these results,
durable and complete follow-up after restrictive procedures
is imperative.
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Mitka M. Surgery for obesity: demand soars amid scientific,
ethical questions. Jama. 2003;289(14):1761–2.
2. Tessier DJ, Eagon JC. Surgical management of morbid obesity.
Curr Probl Surg. 2008;45(2):68–137.
3. Kemper HC, Stasse-Wolthuis M, Bosman W. The prevention and
treatment of overweight and obesity. Summary ofthe advisory report
by the Health Council of The Netherlands. Neth J Med. 2004;62
(1):10–7.
4. Bjorntorp P. Results of conservative therapy of obesity: correla-
tion with adipose tissue morphology. Am J Clin Nutr. 1980;33(2
Suppl):370–5.
5. Fisher BL, Schauer P. Medical and surgical options in the
treatment of severe obesity. Am J Surg. 2002;184(6B):9S–16.
6. Mason EE et al. Vertical gastroplasty: evolution of vertical banded
gastroplasty. World J Surg. 1998;22(9):919–24.
7. Eckhout GV, Willbanks OL, Moore JT. Vertical ring gastroplasty
for morbid obesity. Five year experience with 1,463 patients. Am
J Surg. 1986;152(6):713–6.
8. Catona A et al. Laparoscopic gastric banding: preliminary series.
Obes Surg. 1993;3(2):207–9.
9. van Dielen FM et al. Laparoscopic adjustable gastric banding
versus open vertical banded gastroplasty: a prospective random-
ized trial. Obes Surg. 2005;15(9):1292–8.
10. de Wit LTet al. Open versus laparoscopic adjustable silicone gastric
banding: a prospective randomized trial for treatment of morbid
obesity. Ann Surg. 1999;230(6):800–5. discussion 805–807.
11. Olbers T et al. Randomized clinical trial of laparoscopic Roux-en-
Y gastric bypass versus laparoscopic vertical banded gastroplasty
for obesity. Br J Surg. 2005;92(5):557–62.
12. Morino M et al. Laparoscopic adjustable silicone gastric banding
versus vertical banded gastroplasty in morbidly obese patients: a
prospective randomized controlled clinical trial. Ann Surg.
2003;238(6):835–41. discussion 841-842.
13. Nilsell K et al. Prospective randomised comparison of adjustable
gastric banding and vertical banded gastroplasty for morbid
obesity. Eur J Surg. 2001;167(7):504–9.
14. Miller K, Pump A, Hell E. Vertical banded gastroplasty versus
adjustable gastric banding: prospective long-term follow-up study.
Surg Obes Relat Dis. 2007;3(1):84–90.
15. Schouten R et al. Conversion of vertical banded gastroplasty to
Roux-en-Y gastric bypass results in restoration of the positive
effect on weight loss and co-morbidities: evaluation of 101
patients. Obes Surg. 2007;17(5):622–30.
16. Belachew M et al. Laparoscopic adjustable gastric banding. World
J Surg. 1998;22(9):955–63.
OBES SURG (2010) 20:1617–1626 162517. Dargent J. Pouch dilatation and slippage after adjustable gastric
banding: is it still an issue? Obes Surg. 2003;13(1):111–5.
18. Weiner R et al. A prospective randomized trial of different
laparoscopic gastric banding techniques for morbid obesity. Surg
Endosc. 2001;15(1):63–8.
19. Karlsson J et al. Ten-year trends in health-related quality of life
after surgical and conventional treatment for severe obesity: the
SOS intervention study. Int J Obes (Lond). 2007;31(8):1248–61.
20. Sjostrom L et al. Lifestyle, diabetes, and cardiovascular risk
factors 10 years after bariatric surgery. N Engl J Med. 2004;351
(26):2683–93.
21. Balsiger BM et al. Ten and more years after vertical banded
gastroplasty as primary operation for morbid obesity. J Gastro-
intest Surg. 2000;4(6):598–605.
22. O'Brien PE, Dixon JB. Lap-band: outcomes and results. J
Laparoendosc Adv Surg Tech A. 2003;13(4):265–70.
23. O'Brien PE et al. Systematic review of medium-term weight loss
after bariatric operations. Obes Surg. 2006;16(8):1032–40.
24. Buchwald H et al. Bariatric surgery: a systematic review and
meta-analysis. Jama. 2004;292(14):1724–37.
25. Chapman AE et al. Laparoscopic adjustable gastric banding in the
treatment of obesity: a systematic literature review. Surgery.
2004;135(3):326–51.
26. Colquitt J. et al. Surgery for morbid obesity. Cochrane Database
Syst Rev. 2005(4):CD003641.
27. Pi-Sunyer X et al. Reduction in weight and cardiovascular disease
risk factors in individuals with type 2 diabetes: one-year results of
the look AHEAD trial. Diab Care. 2007;30(6):1374–83.
28. Knowler WC et al. Reduction in the incidence of type 2 diabetes
with lifestyle intervention or metformin. N Engl J Med. 2002;346
(6):393–403.
29. Pournaras DJ, le Roux CW. After bariatric surgery, what vitamins
should be measured and what supplements should be given? Clin
Endocrinol (Oxf). 2009;71(3):322–5.
30. Coupaye M et al. Nutritional consequences of adjustable gastric
banding and gastric bypass: a 1-year prospective study. Obes
Surg. 2009;19(1):56–65.
31. Gasteyger C et al. Changes in body composition, metabolic profile
and nutritional status 24 months after gastric banding. Obes Surg.
2006;16(3):243–50.
32. Cooper PL et al. Nutritional consequences of modified vertical
gastroplasty in obese subjects. Int J Obes Relat Metab Disord.
1999;23(4):382–8.
33. Parkes E. Nutritional management of patients after bariatric
surgery. Am J Med Sci. 2006;331(4):207–13.
34. Malinowski SS. Nutritional and metabolic complications of
bariatric surgery. Am J Med Sci. 2006;331(4):219–25.
35. Fujioka K. Follow-up of nutritional and metabolic problems after
bariatric surgery. Diab Care. 2005;28(2):481–4.
36. Ledoux S et al. Comparison of nutritional consequences of
conventional therapy of obesity, adjustable gastric banding, and
gastric bypass. Obes Surg. 2006;16(8):1041–9.
37. Trostler N et al. Nutrient intake following vertical banded
gastroplasty or gastric bypass. Obes Surg. 1995;5(4):403–10.
38. Hall JC et al. Gastric surgery for morbid obesity. The Adelaide
Study. Ann Surg. 1990;211(4):419–27.
39. van Gemert WG et al. Revisional surgery after failed vertical
banded gastroplasty: restoration of vertical banded gastro-
plasty or conversion to gastric bypass. Obes Surg. 1998;8(1):
21–8.
40. Nightengale ML et al. Prospective evaluation of vertical banded
gastroplasty as the primary operation for morbid obesity. Mayo
Clin Proc. 1991;66(8):773–82.
41. MacLean LD, Rhode BM, Forse RA. Late results of vertical
banded gastroplasty for morbid and super obesity. Surgery.
1990;107(1):20–7.
42. Naslund E et al. Seven year results of vertical banded gastroplasty
for morbid obesity. Eur J Surg. 1997;163(4):281–6.
43. van de Weijgert EJ, Ruseler CH, Elte JW. Long-term follow-up
after gastric surgery for morbid obesity: preoperative weight loss
improves the long-term control of morbid obesity after vertical
banded gastroplasty. Obes Surg. 1999;9(5):426–32.
44. Sugerman HJ et al. Conversion of failed or complicated vertical
banded gastroplasty to gastric bypass in morbid obesity. Am J
Surg. 1996;171(2):263–9.
45. Cordera F et al. Unsatisfactory weight loss after vertical banded
gastroplasty: is conversion to Roux-en-Y gastric bypass success-
ful? Surgery. 2004;136(4):731–7.
46. Kfoury E, Vanguri A. Distal Roux-en-Y gastric bypass conversion
operation for failed vertical banded gastroplasty. Obes Surg.
1993;3(1):41–3.
47. Gonzalez R et al. Operative technique for converting a failed
vertical banded gastroplasty to Roux-en-Y gastric bypass. J Am
Coll Surg. 2005;201(3):366–74.
48. Schouten R, van Dielen FM, Greve JW. Re-operation after
laparoscopic adjustable gastric banding leads to a further decrease
in BMI and obesity-related co-morbidities: results in 33 patients.
Obes Surg. 2006;16(7):821–8.
49. O'Brien PE et al. A prospective randomized trial of placement of
the laparoscopic adjustable gastric band: comparison of the
perigastric and pars flaccida pathways. Obes Surg. 2005;15
(6):820–6.
50. Christou N, Efthimiou E. Five-year outcomes of laparoscopic
adjustable gastric banding and laparoscopic Roux-en-Y gastric
bypass in a comprehensive bariatric surgery program in Canada.
Can J Surg. 2009;52(6):E249–58.
51. Cottam DR et al. A case-controlled matched-pair cohort study of
laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in
a single US center with three-year follow-up. Obes Surg. 2006;16
(5):534–40.
52. Weiss HG et al. Surgical revision after failure of laparoscopic
adjustable gastric banding. Br J Surg. 2004;91(2):235–41.
53. Peterli R et al. Re-operations following laparoscopic adjustable
gastric banding. Obes Surg. 2002;12(6):851–6.
1626 OBES SURG (2010) 20:1617–1626